{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T08:37:54Z","timestamp":1697445474149},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.eururo.2006.01.012","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T14:54:49Z","timestamp":1138373689000},"page":"290-301","source":"Crossref","is-referenced-by-count":6,"title":["Gene Expression in Normal Urothelium Depends on Location within the Bladder: A Possible Link to Bladder Carcinogenesis"],"prefix":"10.1016","volume":"50","author":[{"given":"Sharon C.","family":"Doherty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie R.","family":"McKeown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus A.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian K.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie J.","family":"McKelvey-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.01.012_bib1","first-page":"784","article-title":"Two molecular pathways to transitional cell carcinoma of the bladder","volume":"54","author":"Spruck","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2006.01.012_bib2","first-page":"1035","article-title":"Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen","volume":"12","author":"Stinson","year":"1992","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2006.01.012_bib3","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0090-4295(03)00692-7","article-title":"Analysis of genetic alterations in normal bladder urothelium","volume":"62","author":"Junker","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.01.012_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0022-5347(17)59764-5","article-title":"Tumors of the bladder: a multifaceted problem","volume":"112","author":"Melicow","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.01.012_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1464-410X.1978.tb02816.x","article-title":"The site of recurrence of non-infiltrating bladder tumours","volume":"50","author":"Page","year":"1978","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2006.01.012_bib6","series-title":"Anatomy and physiology of the bladder, trigone and urethra","author":"Hutch","year":"1972"},{"key":"10.1016\/j.eururo.2006.01.012_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1464-410X.1993.tb15876.x","article-title":"Why do most primary bladder neoplasms first appear around the ureteric orifices?","volume":"71","author":"Stewart","year":"1993","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2006.01.012_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/94.7.513","article-title":"Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling","volume":"94","author":"Agrawal","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2006.01.012_bib9","first-page":"44","article-title":"A light and electron microscopic study of the effects of a single dose of cyclophosphamide on various organs in the rat. I. The urinary bladder","volume":"16","author":"Koss","year":"1967","journal-title":"Lab Invest"},{"key":"10.1016\/j.eururo.2006.01.012_bib10","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/S0022-5347(01)64786-4","article-title":"Growth factors in bladder wound healing","volume":"157","author":"Baskin","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.01.012_bib11","first-page":"1","article-title":"The biology of bladder cancer","volume":"51","author":"Cooper","year":"1972","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.eururo.2006.01.012_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/1097-0142(197401)33:1<115::AID-CNCR2820330118>3.0.CO;2-V","article-title":"Histology and cell proliferation in human bladder tumors. An autoradiographic study","volume":"33","author":"Hainau","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2006.01.012_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng1061","article-title":"Identifying distinct classes of bladder carcinoma using microarrays","volume":"33","author":"Dyrskjot","year":"2003","journal-title":"Nat Gen"},{"key":"10.1016\/j.eururo.2006.01.012_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.146.3.573","article-title":"Cdc25B, Cdc25C differ markedly in their properties as initiators of mitosis","volume":"146","author":"Karlsson","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.eururo.2006.01.012_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1042\/bj3560829","article-title":"Interaction of human thymidine kinase 1 with p21(Waf1)","volume":"356","author":"Huang","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.eururo.2006.01.012_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/A:1022490512705","article-title":"The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy","volume":"29","author":"Mazurek","year":"1997","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.eururo.2006.01.012_bib17","first-page":"544","article-title":"Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism","volume":"50","author":"Kaplan","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2006.01.012_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0076-6879(82)90121-5","article-title":"Pyruvate kinase isozymes from rat","volume":"90 Pt E","author":"Imamura","year":"1982","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.eururo.2006.01.012_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/02688698808992677","article-title":"The pyruvate kinase isoenzyme shift in human gliomas: a potential marker in the treatment of gliomas","volume":"2","author":"Van Veelen","year":"1988","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.eururo.2006.01.012_bib20","first-page":"2019","article-title":"Quantitative determination of the degree of differentiation of mammary tumors by pyruvate kinase kinetic analysis","volume":"41","author":"Lopez-Alarcon","year":"1981","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2006.01.012_bib21","first-page":"1439","article-title":"Isozymes of pyruvate kinase in liver and hepatomas of the rat","volume":"34","author":"Farina","year":"1974","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2006.01.012_bib22","doi-asserted-by":"crossref","first-page":"15149","DOI":"10.1073\/pnas.211566398","article-title":"Multiclass cancer diagnosis using tumour gene expression signatures","volume":"98","author":"Ramaswamy","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.eururo.2006.01.012_bib23","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1523\/JNEUROSCI.20-19-07345.2000","article-title":"The human DIMINUTO\/DWARF1 homolog seladin-1 confers resistance to Alzheimer\u2019s disease-associated neurodegeneration and oxidative stress","volume":"20","author":"Greeve","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.eururo.2006.01.012_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/dnares\/1.1.47","article-title":"Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement)","volume":"1","author":"Nomura","year":"1994","journal-title":"DNA Res"},{"key":"10.1016\/j.eururo.2006.01.012_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/323473","article-title":"Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis","volume":"69","author":"Waterham","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.eururo.2006.01.012_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-4608(98)00193-9","article-title":"Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis","volume":"110","author":"Koo","year":"1999","journal-title":"Cancer Genet and Cytogenetics"},{"key":"10.1016\/j.eururo.2006.01.012_bib27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature03173","article-title":"Regulation of cellular response to oncogenic and oxidative stress by Seladin-1","volume":"432","author":"Wu","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2006.01.012_bib28","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1210\/jcem.86.11.8032","article-title":"The human homolog of Diminuto\/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas","volume":"86","author":"Sarkar","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2006.01.012_bib29","first-page":"1425","article-title":"Differentially expressed genes and estrogen receptor status in breast cancer","volume":"23","author":"Nagai","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.eururo.2006.01.012_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1749-6632.2002.tb05955.x","article-title":"Identifying immunotherapeutic targets for prostate carcinoma through the analysis of gene expression profiles","volume":"975","author":"Nelson","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.eururo.2006.01.012_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2004.01.012","article-title":"Molecular mechanisms of prostate cancer","volume":"45","author":"Porkka","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.01.012_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jcb.20412","article-title":"Genetic and epigenetic aspects of bladder cancer","volume":"95","author":"Kim","year":"2005","journal-title":"J Cell Biochem"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T16:22:25Z","timestamp":1555431745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0302283806000315"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.01.012","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}